Comparison of the Combined Nystatin, Di-iodohydroxyquin and Benzalkonium Chloride Vaginal Tablet and Oral Metronidazole in the Treatment of Bacterial Vaginosis: Randomized Controlled Trial

Phase 1

Recruiting

• Conditions: Bacterial vaginosis; metronidazole; Nystatin; Di- iodohydroxyquin; Benzalkonium Chloride; Vaginal Tablet; GYNECON; GYNECO

• Registration Number: TCTR20170627001
• Lead Sponsor: Research affairs, Faculty of Medicine, Khon Kaen university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-06-27
• Study Completion: 2017-12-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 170

Inclusion Criteria

diagnosis of bacterial vaginosis
age 18-60

Exclusion Criteria

Allergy to Metronidazole, GYNECON
History of bleeding per vagina(unknown cause) within 3 months
History of vaginal tablet use within 1 month
History of vaginal douche within 48 hours
History of sexual intercourse with no barrier within 24 hours
History of sexual transmitted diseases

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cure rate of Bacterial vaginosis 14 days Amsel criteria

Secondary Outcome Measures

Name	Time	Method
side effect of medicine 14 days, 42 days Amsel criteria,patient satisfaction 14 days questionnaires